145 related articles for article (PubMed ID: 28385775)
1. Variant
Dowse RT; Ireland RM
Blood; 2017 Apr; 129(14):2038. PubMed ID: 28385775
[No Abstract] [Full Text] [Related]
2. A case of acute promyelocytic leukaemia with unusual cytological features and a ZBTB16-RARA fusion gene.
Lechevalier N; Dulucq S; Bidet A
Br J Haematol; 2016 Aug; 174(4):502. PubMed ID: 27302179
[No Abstract] [Full Text] [Related]
3. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
[TBL] [Abstract][Full Text] [Related]
4. Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA.
Morimoto S; Kondo T; Taya T; Matsuo H; Teramoto Y; Mizumoto C; Kanda J; Yamashita K; Takaori-Kondo A
Ann Hematol; 2022 May; 101(5):1129-1132. PubMed ID: 35347397
[No Abstract] [Full Text] [Related]
5. Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA.
Li H; Xiang X; Ding H; Yu J; Xu J; Yuan Y; Wu Y
Br J Haematol; 2022 Dec; 199(5):768-771. PubMed ID: 36169236
[No Abstract] [Full Text] [Related]
6. ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report.
Pardo Gambarte L; Franganillo Suárez A; Cornago Navascués J; Soto de Ozaeta C; Blas López C; Atance Pasarisas M; Salgado Sánchez RN; Serrano Del Castillo C; Mata Serna R; Velasco Rodríguez D; López-Lorenzo JL; Llamas-Sillero P; Solán Blanco L
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454359
[TBL] [Abstract][Full Text] [Related]
7. Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.
King D; Foucar CE; Ma V; Benitez L; Perissinotti AJ; Marini BL; Robinson D; Bhave RR; Bixby D
Cancer Genet; 2021 Nov; 258-259():57-60. PubMed ID: 34534739
[TBL] [Abstract][Full Text] [Related]
8. Round Promyelocyte Cells with Round Nuclei: Clues to the Diagnosis of
Su Y; Zhao J; Fan X; Yang W; Liu J
Turk J Haematol; 2023 Dec; 40(4):273-274. PubMed ID: 37314303
[No Abstract] [Full Text] [Related]
9. Recurrent
Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
[TBL] [Abstract][Full Text] [Related]
10. Acute Promyelocytic Leukemia: A Review and Discussion of Variant Translocations.
Adams J; Nassiri M
Arch Pathol Lab Med; 2015 Oct; 139(10):1308-13. PubMed ID: 26414475
[TBL] [Abstract][Full Text] [Related]
11. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel recurrent
Yao L; Wen L; Wang N; Liu T; Xu Y; Ruan C; Wu D; Chen S
Blood; 2018 Feb; 131(8):935-939. PubMed ID: 29237593
[No Abstract] [Full Text] [Related]
13. Microfluidic-Based Detection of AML-Specific Biomarkers Using the Example of Promyelocyte Leukemia.
Emde B; Kreher H; Bäumer N; Bäumer S; Bouwes D; Tickenbrock L
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255664
[TBL] [Abstract][Full Text] [Related]
14. The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.
Swaney EM; Chattopadhyay A; Abecassis I; Rush EA; Redner RL
Leuk Lymphoma; 2016 Aug; 57(8):1933-7. PubMed ID: 26754533
[TBL] [Abstract][Full Text] [Related]
15. FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
Cheng CK; Wang AZ; Wong THY; Wan TSK; Cheung JS; Raghupathy R; Chan NPH; Ng MHL
Blood; 2017 May; 129(19):2705-2709. PubMed ID: 28314734
[No Abstract] [Full Text] [Related]
16. Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
[TBL] [Abstract][Full Text] [Related]
17. Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
Iaccarino L; Divona M; Ottone T; Cicconi L; Lavorgna S; Ciardi C; Alfonso V; Travaglini S; Facchini L; Cimino G; Di Bona E; Voso MT; Lo-Coco F
Genes Chromosomes Cancer; 2019 Jan; 58(1):60-65. PubMed ID: 30421475
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
Greenfield G; Michail O; Merron B; McGimpsey J; Catherwood M; McMullin MF
Br J Haematol; 2019 Jul; 186(1):155-157. PubMed ID: 30585303
[No Abstract] [Full Text] [Related]
19. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
20. Acute promyelocytic leukemia (APL) with an
Alotaibi AS; Abdulrazzaq M; Patel KP; Ravandi F; Konoplev S; Bueso-Ramos C; Yin CC; Muzzafar T; Tang G; Futreal A; Jain N; Konopleva MY; Pemmaraju N
Leuk Lymphoma; 2020 Dec; 61(12):3018-3020. PubMed ID: 32657180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
